Erowid References Database
|
Hekmatpanah CR, McKenna DJ, Peroutka SJ.
“Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat”.
Neurosci Lett. 1989;104(1-2):178-82.
|
|
Abstract
3,4-Methylenedioxymethamphetamine (MDMA; 'Ecstasy') is a known neurotoxin to 5-hydroxytryptamine (5-HT) nerve terminals. Recent studies have suggested that endogenous dopamine (DA) and/or 5-HT may mediate the MDMA-induced neurotoxicity. The central monoamine stores of rats were significantly decreased with reserpine (5 mg/kg) prior to toxic injections of MDMA. Rats given MDMA (30 mg/kg) displayed significant decreases in the density of 5-HT nerve terminals labeled by [3H]paroxetine both with (51 +/- 8%) and without (43 +/- 20%) reserpine pre-treatment. These data suggest that the degeneration of 5-HT nerve terminals following MDMA is independent of the presence of endogenous stores of DA or 5-HT.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
